LF-rTMS also upregulates striatal dopamine D2-receptor expression, enhances dopaminergic signaling, and alleviates Parkinson’s disease-associated REM sleep behavior disorder (RBD) (Ahmed et al., 2012). The gene discussed is DRD2; the disease is REM sleep behavior disorder.